Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ameet Perez

Physician Assistant Smithtown, NY Physician Assistant

NPI 1689895989 CMS profile 10462305

222 Middle Country Rd Ste 228, Smithtown, NY 11787

Open in the dashboard

General payments

$4,080

177 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ameet Perez of Smithtown, NY is reported in the CMS Open Payments database as having received $4,080 across 177 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,198 41
2024 General $781 39
2023 General $535 26
2022 General $1,108 48
2021 General $457 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ameet Perez
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Ameet Perez were reported at $1,198. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Ameet Perez Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $457 $132 $37–$438 $132
2022 $1,108 $155 $48–$522 $149
2023 $535 $167 $52–$557 $160
2024 $781 $178 $55–$600 $164
2025 $1,198 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $561 22 payments
  2. Regeneron Healthcare Solutions, Inc. $495 13 payments
  3. Janssen Biotech, Inc. $371 12 payments
  4. Novartis Pharmaceuticals Corporation $344 16 payments
  5. Genzyme Corporation $341 14 payments
  6. Amgen Inc. $296 11 payments
  7. Ortho Dermatologics, a division of Bausch Health US, LLC $240 11 payments
  8. Sun Pharmaceutical Industries Inc. $232 10 payments
  9. Dermavant Sciences, Inc. $183 14 payments
  10. Incyte Corporation $165 9 payments
  11. Other $851 45 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,973 175 payments
  2. Education $107 2 payments
Products named General payments · program years 2021–2025
  1. DUPIXENT Immunology $483 19 payments
  2. DUPIXENT Immunology And Inflammation $407 10 payments
  3. Otezla $296 11 payments
  4. TREMFYA $239 7 payments
  5. SKYRIZI $229 11 payments
  6. SIMPONI ARIA $198 8 payments
  7. STELARA $198 8 payments
  8. SIMPONI $198 8 payments
  9. VTAMA $183 14 payments
  10. RINVOQ $177 5 payments
  11. Other $2,720 131 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

177 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record